Journal of Commercial Biotechnology — May 2011 issue now available

Journal of Commercial Biotechnology — May 2011 issue now available

The May 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 17, Issue 2

Editorial

Building biotechnology in Okinawa PDF
Yali Friedman

Commentary

Startup America: What it includes and opportunities for innovators PDF
David B Orange
Singapore – Home base for expansion in Asia PDF
Kian-Teik Beh
Traditional ecological knowledge: Impact on commercial health PDF
Mohammadali Khalvati, Ikway (Yvonne Fulton) Michine, Wabiska (Zane Bell) Mukwa, Mary Jane Metatawabin

Articles

The growing importance of incorporating US payers into biotechnology drug development decision-making PDF
Sarah Collins
Anticipating opportunities in industrial biotechnology: Sizing the market and growth scenarios PDF
Peter J Nieuwenhuizen, David Lyon
Founding angels as early stage investment model to foster biotechnology start-ups PDF
Gunter Festel
The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticals PDF
James Kaufman, Nicholas Kalaitzandonakes

From the Classroom

Developing graduate skills for the United Kingdom’s commercial life science sector: Experiences from the ORBIS internship programme PDF
James Gazzard

Legal and Regulatory Updates

EU Legal and Regulatory Update PDF
Gerry Kamstra
Impact of recent IP caselaw on biomarkers and personalized medicine PDF
David A Gass
Licensing issues in today’s bankruptcy world PDF
Michael Schein, Brandon J Fleischman
Limitation of gene patents to functioning DNA PDF
Philip Webber

Book Reviews

Chronicling the development of myozyme: The Cure and Chasing Miracles PDF
Derek J Francis
Anatomy of a Patent Case PDF
Michael G Sullivan

NO COMMENTS

Leave a Reply